Correlation Between Monopar Therapeutics and Wilmar International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Wilmar International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Wilmar International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Wilmar International Limited, you can compare the effects of market volatilities on Monopar Therapeutics and Wilmar International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Wilmar International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Wilmar International.

Diversification Opportunities for Monopar Therapeutics and Wilmar International

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Monopar and Wilmar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Wilmar International Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wilmar International and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Wilmar International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wilmar International has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Wilmar International go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Wilmar International

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 9.25 times more return on investment than Wilmar International. However, Monopar Therapeutics is 9.25 times more volatile than Wilmar International Limited. It trades about 0.09 of its potential returns per unit of risk. Wilmar International Limited is currently generating about 0.03 per unit of risk. If you would invest  175.00  in Monopar Therapeutics on November 5, 2024 and sell it today you would earn a total of  4,219  from holding Monopar Therapeutics or generate 2410.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy81.71%
ValuesDaily Returns

Monopar Therapeutics  vs.  Wilmar International Limited

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Wilmar International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Wilmar International Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Monopar Therapeutics and Wilmar International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and Wilmar International

The main advantage of trading using opposite Monopar Therapeutics and Wilmar International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Wilmar International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wilmar International will offset losses from the drop in Wilmar International's long position.
The idea behind Monopar Therapeutics and Wilmar International Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies